Rhesus macaque model for ovarian cancer chemoprevention

Area of Science:

• Primate models in oncology research
• Ovarian cancer chemoprevention strategies

Background:

• Ovarian cancer remains a significant health challenge.
• Development of effective chemoprevention strategies is crucial.
• Nonhuman primate models offer translational potential for human disease research.

Purpose of the Study:

• To evaluate the feasibility of using a nonhuman primate model for ovarian cancer chemoprevention.
• To assess the tolerance of rhesus macaques to fenretinide and oral contraceptives.
• To identify potential biomarkers for ovarian cancer prevention studies.

Main Methods:

• A feasibility trial involving 19 female rhesus macaques (Macacca mulatta).
• Administration of fenretinide (4HPR), oral contraceptive pills (OCP), or a combination for three months.
• Ovarian biopsy specimens obtained via laparotomy before and after drug administration for analysis.

Main Results:

• Rhesus macaques demonstrated tolerance to fenretinide, oral contraceptives, and surgical procedures with minimal morbidity.
• Acquisition of multiple ovarian biopsy specimens was feasible.
• Fluorescence spectroscopy emerged as a promising biomarker for ovarian cancer prevention studies.

Conclusions:

• The rhesus macaque model is well-tolerated and suitable for ovarian cancer chemoprevention research.
• This nonhuman primate model warrants further investigation for its potential in preclinical studies.
• Fluorescence spectroscopy shows promise as a biomarker in this model.